President Donald Trump announced Thursday that a common drug used to fight malaria has shown great promise in treating people infected with COVID-19.
The drug, chloroquine, is a medication used to prevent and to treat malaria, as well as a type of liver infection. It was first used to treat malaria in 1944. Excitement has grown about the use of the drug to fight COVID-19, with research studies showing chloroquine is effective at preventing and treating the virus that causes severe acute respiratory syndrome. SARS is in the same coronavirus family as COVID-19.
"There is evidence that chloroquine is effective when they looked at SARS in vitro with primate cells," Dr. Len Horovitz, a pulmonologist and internist at Lenox Hill Hospital in New York City, told ABC News. "The theory of the experiment with primate cells was that chloroquine could be for preventing viral infection or as a treatment for viral infection after it had occurred.”
The World Health Organization announced Wednesday that it is launching a multicounty clinical trial to test four drugs as potential COVID-19 therapies. Chloroquine is one of the drugs.
The other drugs are the antiviral drug remdesivir; a combination of two HIV drugs, lopinavir and ritonavir; and lopinavir and ritonavir plus interferon beta.
All four of the drugs have shown potential to be effective against COVID-19, either in animal studies or in studies done in laboratories. Ten countries have already indicated they will take part in the trial -- Argentina, Bahrain, Canada, France, Iran, Norway, South Africa, Spain, Switzerland and Thailand.
How does it work?
People become infected with both SARS and COVID-19 when protein spikes on the surfaces of those viruses bind to special receptors on the outside of human cells.
Chloroquine worked against SARS by interfering with those receptors, thereby interfering with the virus’s ability to bind to cells. Researchers believe there is a chance Chloroquine can do the same against COVID-19.
"The way that it worked against SARS was by preventing of the attachment of the virus to the cells. Chloroquine interfered with the attachment to that receptor on the cell membrane surface," Horovitz said. "So it’s disrupting a lock and key kind of mechanism of attachment."
Researchers plan to test chloroquine in health care workers to see if it can help prevent them from getting the virus.
According to Medscape, chloroquine combined with the antibiotic azithromycin has shown to reduce the amount of virus in patients with COVID-19.